Spironolactone and Symlin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spironolactone (spironolactone) and Symlin (pramlintide acetate). Common drug interactions include gastrooesophageal reflux disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Spironolactone and Symlin. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Symlin?

Symlin has active ingredients of pramlintide acetate. It is often used in diabetes. eHealthMe is studying from 3,359 Symlin users. Check the latest studies of Symlin.



On Jul, 26, 2026

24 people who take Spironolactone and Symlin together, and have interactions are studied.

Spironolactone and Symlin drug interactions.

What are the common drug interactions of Spironolactone and Symlin, by gender? *:

female:

  1. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  2. Heart rate irregular
  3. Hyperhidrosis (abnormally increased sweating)
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Nausea (feeling of having an urge to vomit)
  8. Weight increased
  9. Dizziness
  10. Vomiting

male:

  1. Chronic kidney disease
  2. Blood glucose decreased
  3. Diarrhoea
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hunger
  6. Leukocytosis (increased white blood cells)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  9. Nausea (feeling of having an urge to vomit)
  10. Peritoneal dialysis complication

What are the common drug interactions of Spironolactone and Symlin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

  1. Chronic kidney disease
  2. Depression
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

40-49:

  1. Hyperglycaemia (high blood sugar)
  2. Hypotension (abnormally low blood pressure)
  3. Overdose
  4. Pain
  5. Perfume sensitivity
  6. Pneumonia
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Respiratory distress (difficulty in breathing)
  9. Sluggishness (lacking alertness)
  10. Suicide attempt

50-59:

  1. Injection site pain

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Weight increased
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Injection site erythema (redness at injection site)
  7. Injection site pain
  8. Pulmonary hypertension (increase in blood pressure in the lung artery)
  9. Vomiting
  10. Abdominal pain

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 6 people, 25.00%
  2. High Blood Cholesterol: 6 people, 25.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 25.00%
  4. Gout (uric acid crystals building up in the body): 4 people, 16.67%
  5. Depression: 4 people, 16.67%
  6. Thyroid Diseases: 3 people, 12.50%
  7. Pain: 3 people, 12.50%
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 12.50%
  9. Muscle Spasms (muscle contraction): 3 people, 12.50%
  10. Kidney Stones: 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and Symlin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Spironolactone and Symlin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Symlin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spironolactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Symlin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone and pramlintide acetate (the active ingredients of Spironolactone and Symlin, respectively), and Spironolactone and Symlin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: